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ABSTRACT Small molecules are the primary communication media of the microbial
world. Recent bioinformatic studies, exploring the biosynthetic gene clusters (BGCs)
which produce many small molecules, have highlighted the incredible biochemical
potential of the signaling molecules encoded by the human microbiome. Thus far,
most research efforts have focused on understanding the social language of the gut
microbiome, leaving crucial signaling molecules produced by oral bacteria and their
connection to health versus disease in need of investigation. In this study, a total of
4,915 BGCs were identified across 461 genomes representing a broad taxonomic di-
versity of oral bacteria. Sequence similarity networking provided a putative product
class for more than 100 unclassified novel BGCs. The newly identified BGCs were
cross-referenced against 254 metagenomes and metatranscriptomes derived from in-
dividuals either with good oral health or with dental caries or periodontitis. This
analysis revealed 2,473 BGCs, which were differentially represented across the oral
microbiomes associated with health versus disease. Coabundance network analy-
sis identified numerous inverse correlations between BGCs and specific oral taxa.
These correlations were present in healthy individuals but greatly reduced in in-
dividuals with dental caries, which may suggest a defect in colonization resis-
tance. Finally, corroborating mass spectrometry identified several compounds
with homology to products of the predicted BGC classes. Together, these find-
ings greatly expand the number of known biosynthetic pathways present in the
oral microbiome and provide an atlas for experimental characterization of these
abundant, yet poorly understood, molecules and socio-chemical relationships,
which impact the development of caries and periodontitis, two of the world’s
most common chronic diseases.
IMPORTANCE The healthy oral microbiome is symbiotic with the human host, im-
portantly providing colonization resistance against potential pathogens. Dental car-
ies and periodontitis are two of the world’s most common and costly chronic infec-
tious diseases and are caused by a localized dysbiosis of the oral microbiome.
Bacterially produced small molecules, often encoded by BGCs, are the primary com-
munication media of bacterial communities and play a crucial, yet largely unknown,
role in the transition from health to dysbiosis. This study provides a comprehensive
mapping of the BGC repertoire of the human oral microbiome and identifies major
differences in health compared to disease. Furthermore, BGC representation and ex-
pression is linked to the abundance of particular oral bacterial taxa in health versus
dental caries and periodontitis. Overall, this study provides a significant insight into
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the chemical communication network of the healthy oral microbiome and how it
devolves in the case of two prominent diseases.
KEYWORDS biosynthetic gene clusters, caries, genome mining, oral microbiome,
periodontitis, small molecules
The human body is inhabited by rich and diverse bacterial communities, which areintimately linked to the health of the human host (1). Small molecules, which are
often encoded by biosynthetic gene clusters (BGCs), are the primary means of com-
munication in this microbial world. Recent studies suggest that the human microbiota
has the potential to synthesize structurally diverse small molecules and that these small
molecules serve as mediators in a variety of microbe-microbe and host-microbe
interactions (2–4). These interactions include antibacterial activity (5), bacterial signal-
ing (6), immune modulation (7), biofilm formation (8, 9), host colonization (10), nutrient
scavenging (11), and stress protection (12). Disruption of the finely tuned equilibrium
of the bacterial ecosystems in the human microbiome, referred to as dysbiosis, is
associated with a plethora of diseases. While the mechanistic underpinnings of a shift
to a dysbiotic community remain poorly understood, there is little doubt that signaling
via the small molecules produced by microbial BGCs plays a critical role in the transition
to dysbiosis and associated pathogenesis (13, 14).
The human oral cavity contains an assortment of ecological niches, and as such, harbors
one of the most diverse microbial populations in the human body (1, 15). Dental caries and
periodontitis are two of the most common and costly chronic conditions afflicting humans
and are the result of localized dysbiosis in the oral cavity (16–20). Unlike the rest of the
human digestive tract, the oral cavity is consistently exposed to the exterior environment.
Therefore, an indispensable portion of the first line of defense against invading pathogens
is the colonization resistance provided by a healthy oral microbiome. Indeed, dysbiosis of
the oral microbiome is not only directly linked to oral diseases but is also implicated in
system-wide health (21), stressing the urgent need to unravel the underlying factors that
shape and maintain a healthy human oral microbiome.
Elucidating the transmissions relayed by oral bacterial small molecules could lead to
a deeper understanding of key ecological factors that set the stage for oral community
succession, in health and pathogenesis. A large and growing body of literature suggests
that the microbial composition and metabolic potential of the saliva and dental plaque
varies significantly in healthy versus disease states (22–28). Therefore, we hypothesize
that the abundance and expression of BGCs, which produce small molecules, may drive
crucial bacterial interactions which contribute to health or disease. To explore this further,
the biosynthetic capacity of 461 well-annotated oral bacterial genomes was investigated,
and an enormous diversity of BGCs was revealed. In addition, sequence reads from 294
publicly available metagenomes and metatranscriptomes, which were associated with
health, dental caries, or periodontitis, were mapped to these novel oral BGCs. This analysis
identified 2,473 biosynthetic pathways which were differentially represented in health
versus disease. In addition, the BGC content in salivary metagenomes obtained from 24
healthy children and 23 children with dental caries was analyzed. A Bayesian network
approach was employed to identify both positive and inverse correlations between BGCs
and bacterial taxa, which revealed differentially abundant signaling networks and species in
health compared to dental caries. Overall, this study provides significant insight into the
chemical communication network of the healthy oral microbiome and how it devolves in
the case of dental caries and periodontitis.
RESULTS AND DISCUSSION
The human oral microbiome encodes thousands of diverse BGCs from an array
of species. To explore the metabolic capacity of the human oral microbiome in depth,
a comprehensive pipeline for mining bacterial genomes was established, utilizing
antiSMASH infrastructure v4 (accessible at https://antismash.secondarymetabolites
.org/) (29), including MultiGeneBlast (30). An oral bacterial genome sequence database
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was assembled to include a total of 461 well-curated and annotated bacterial genomes,
representing 113 unique bacterial genera and 298 taxonomically unique species, as
well as 72 taxa unclassified at the species level (see Table S1 posted at https://massive
.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1). A few
genomes representing transient exogenous bacteria (e.g., legume symbiont Mesorhizobium
loti, pathogenic Yersinia pestis), which also have oral taxon IDs in the Human Oral Micro-
biome Database (HOMD) were included in our analysis to represent an additional source of
unexplored BGC diversity. However, our sequence read mapping exercises (both with
regards to metagenomic and metatranscriptomic reads) showed that most of these BGCs
were of less importance, indicating that the majority were either of low abundance or
absent in the oral cavity (Table S2 posted at https://massive.ucsd.edu/ProteoSAFe/
status.jsp?task1ed182b005a74b94ac730f769b2f37b1). Genomes were selected based
on their completeness and level of annotation. A single genome sequence for each
bacterial species was included to circumvent the overrepresentation of BGCs from
bacteria with a high number of genome representatives. Indeed, in a previous bioin-
formatic study of 169 Streptococcus mutans genomes, 1,000 putative BGCs were
identified, revealing an incredible potential to produce small molecules within one
bacterial species (31). Therefore, it should be noted that the estimated BGC diversity
reported here is likely underestimated. Clearly, strain-level diversity is important to
explore in future studies. However, this will require extensive genome sequencing,
since to date, most oral bacterial species lack multiple reference genomes. By applying
the genome-mining pipeline described above, a total of 4,915 BGCs of known and
unknown types were identified (Table S1 posted at https://massive.ucsd.edu/
ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1). BGCs annotated
as fatty acid synthases, which are often involved in primary metabolism, were excluded.
Approximately 50% of the identified BGCs were of an unknown class, congruent with
the observations of other efforts to identify BGCs (Table S1 posted at the above
website) (2). The remaining 50% of BGCs (2,250) shared sequence similarities with an
extensive range of previously characterized BGC classes, which is likely reflective of the
high taxonomic diversity observed within the oral cavity compared to many other body
sites (1) (Fig. 1A).
Of the BGCs of a known class, a substantial fraction (1,398 BGCs [62%]) were
annotated as oligosaccharides, making it the most abundant class of BGCs in the oral
cavity. Oligosaccharide pathways are widely distributed across bacterial phyla and are
predominant in Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacte-
ria, with the highest number being identified in Firmicutes (Fig. 1B and C). However, the
high abundance of Firmicutes BGCs may reflect that Streptococcus genomes are highly
sequenced compared to genomes of other oral taxa which may have added bias to the
analysis. The ecological roles of oligosaccharides are underexplored, but studies show
important functions such as capsule formation in virulence development (32) and
attachment to surfaces, including neighboring bacterial species and host cells (33).
Furthermore, diffusible oligosaccharides are known to display antibacterial activities
(34); for example, a previous study showed that polysaccharide A from the human gut
bacterium Bacteroides fragilis can modulate the gut mucosal immune response (35, 36).
Another highly represented BGC class was ribosomally synthesized and posttrans-
lationally modified peptides (RiPPs), for which 209 BGCs (9.3% of BGCs of a known class)
were identified. RiPPs include molecules such as bacteriocins, lantipeptides, sactipep-
tides, cyanobactins, and proteusins (denoted as fluorescent green in Fig. 1). Of these
RiPP types, bacteriocin-encoding BGCs were the most abundant, as they contributed
75% of the total RiPP diversity. Interestingly, although bacteriocin-producing BGCs
were abundant in the oral microbiome overall, they were depleted in all Bacteroidetes
genomes (Fig. 1C). The role of RiPPs, such as the bacteriocins, demands further
exploration, as they exhibit antagonistic activities against other microbes sharing the
same ecological niche and influence competition for persistence between commensals
and pathogens (37, 38). Furthermore, multiple studies of genetic transformation in
Streptococcus show that competence is tightly linked to bacteriocin production (39),
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FIG 1 The oral microbiome contains a massive diversity of BGCs encoded by a multitude of taxa. (A) Bar graph illustrating the most common BGC subtypes
identified in this study. Bars are colored according to higher level BGC class. (B) Bar graph illustrating the distribution of eight major classes of BGCs by phyla.
(Continued on next page)
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which suggests that these molecules also play important roles in the horizontal transfer
of genes and ultimately in niche differentiation and population structure changes.
BGCs encoding aryl polyene-like molecules in several Bacteroidetes and Proteobac-
teria genomes were identified (131 BGCs or 5.8% of BGCs of a known class). Aryl
polyenes are predicted to function as protective agents against oxidative stress (40).
However, only a few candidates have been experimentally characterized, leaving this
group of small molecules highly underexplored. A diversity of nonribosomal peptide
synthetases (NRPSs), polyketide synthase (PKS), and NRPS-PKS hybrid BGCs (ranging
between 0.9% and 4.4% of BGCs of a known class) were identified, in line with a prior
study, which classified BGCs in the human microbiome in multiple body habitats (2). In
the same study, it was also observed that BGCs show biogeographic signatures within
the oral cavity, which suggests that different social signaling skills are required to
inhabit different ecological niches. NRPS and PKS compound classes are known for their
antimicrobial activities and were previously characterized as possessing various nutri-
ent scavenging, immunosuppressant, surfactant, and cytotoxic properties (41). BGCs of
the terpene class were also identified (95 BGCs, 4.2% of BGCs of a known class). This
diverse group of small molecules may also be of ecological and medicinal interest, since
their activities have been reported as both anti-inflammatory and antimicrobial (42).
The class “other” encompasses BGCs that fall outside the known categories of antiS-
MASH annotation, includes rare classes found in only a few species, and constituted
9.4% of the total BGCs identified (Fig. 1A). Taken together, these results show that the
oral microbiome encodes a vast and highly diverse array of small molecules that have
largely unexplored, yet likely pivotal, roles in ecology and health.
Sequence similarity networks reveals distant and close homologies to well-
studied classes of BGCs. In order to assess the evolutionary relationships between
conserved domains in the proteins encoded by BGCs, as well as to group BGCs of
similar putative function to evaluate novelty, a sequence similarity network approach
was applied (see Text S1 in the supplemental material). Briefly, the BGCs that were
identified from the bacterial genomes using antiSMASH were aligned to the MIBiG
repository (43) of 1,409 experimentally validated reference BGCs using the BiG-SCAPE
algorithm (https://git.wageningenur.nl/medema-group/BiG-SCAPE). The resulting net-
work comprised 4,242 nodes and 19,847 connecting edges, revealing both close and
distant homology to characterized biosynthetic pathways (Fig. 2). Notably, a significant
fraction of the previously unclassified BGCs did subnetwork with BGCs predicted to be
of a known class, particularly the oligosaccharide, RiPP, and aryl polyene classes (Fig. 2).
These data provide inferences as to the function of more than 100 previously unclas-
sified novel BGCs.
The largest subnetwork, comprised of mainly oligosaccharide-encoding BGCs,
showed no significant homology with any experimentally validated BGCs in the MIBiG
repository (Fig. 2). This may be due to the fact that oligosaccharide-producing BGCs are
at times categorized with primary metabolism, and not natural product-producing
BGCs, as is the case in this study. The second-largest major subnetwork was comprised
of primarily unclassified BGCs. These may encompass distinct chemical scaffolds and
may represent a rich source of novel BGC types. The NRPS, PKS, NRPS-PKS hybrids, and
a few terpene BGCs, grouped together, forming a subnetwork implying a set of
common core domains involved in these biosynthetic assembly lines as described
previously (4, 41). The majority of NRPS, PKS, NRPS-PKS hybrids, and RiPPs (in particular
thiopeptides and lantipeptides) showed strong associations with MIBiG reference BGC
sequences. It should be noted that these are the most prevalent classes in the MIBiG
FIG 1 Legend (Continued)
(C) Phylogenetic tree based on 16S rRNA gene sequences showing the distribution of BGCs encoded by oral bacteria. Nodes with bootstrap values higher
than 80% are displayed in the tree. The numbers of BGC types identified within each genome are shown in the bar graph and colored by BGC type. Leaf
labels are colored by phyla. antiSMASH often identifies BGCs that encompass multiple gene clusters of different types fused into a single large gene cluster.
Sixty-three (3%) of such unresolved BGCs were encountered and categorized as the “complex” BGC type (for convenience, we combined these BGCs with
BGC types “Other” for subsequent analysis).
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FIG 2 Similarity networking identified putative product classes for novel BGCs. Similarity networks between the BGCs identified
in the oral cavity and the experimentally characterized reference BGCs obtained from the MIBiG repository are depicted.
(Continued on next page)
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repository (Table S1 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task
1ed182b005a74b94ac730f769b2f37b1). Currently, only four experimentally character-
ized aryl polyene BGCs exist in the MIBiG database; therefore, it was not surprising that
none of the nodes in the aryl polyene cluster subnetworked with MIBiG reference BGCs.
Given that aryl polyenes are thought to be the most abundant BGC class in the human
microbiome (4), this indicates that this class of molecules is severely understudied
(Fig. 1; see also Table S1 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task
1ed182b005a74b94ac730f769b2f37b1). Several BGCs annotated as saccharides,
other, unclassified, PKS and NRPS BGC types grouped with aryl polyene BGCs, which
may represent novel hybrid classes of BGCs. Other small subnetworks include biosyn-
thesis of terpene phenazine, homoserine lactone, alkaloid, siderophore, and ectoine.
These subnetworks did not associate with MIBiG reference BGCs, indicating that they
also await experimental validation. Our implemented analysis approach, using the
MIBiG/BiG-SCAPE pipeline, is powerful with regard to predicting the functions of novel
BGCs. The annotations we generated here provide deeper insights of which BGCs and
compound classes are most likely to be identified in futures studies, due to knowledge
of their closest neighbor’s biochemical properties. The BGCs remaining with completely
unknown functions represent exciting future challenges, which could be addressed by
generating large-insert BGC expression libraries.
While antiSMASH and network analysis were employed for broad classification of
BGCs into known classes, MultiGeneBlast was also utilized at the level of the entire gene
cluster to further annotate BGCs in depth and identify homologs against the MIBiG
repository (30). Using this approach, the 4,915 BGCs were classified into four major
categories based upon the level of homology to known experimentally validated BGCs
in the MIBiG repository. This categorization resulted in 1,146 (20%) BGCs closely
homologous, 848 (15%) BGCs moderately homologous, and 2,221 (40%) BGCs distantly
homologous to well-characterized BGCs (see Fig. S1 in the supplemental material). A
total of 1,393 (25%) BGCs did not appear to have significant homology to BGCs in
MIBiG, based upon the E value (see Materials and Methods for details). Such a detailed
annotation of BGCs harbored by the human oral microbiome has not been accom-
plished previously.
Specific BGCs and bacterial taxa are associated with periodontitis and dental
caries. We next systematically examined the differential representation of bacterial
BGCs in saliva and dental plaque across 294 human subjects with good oral health,
dental caries, or periodontitis. The data from 247 subjects were obtained from eight
previous studies, which represented all publicly available metagenomes and metatran-
scriptomes associated with caries or periodontal disease compared to oral health at the
time of this study (28 December 2017; Table S2 posted at https://massive.ucsd.edu/
ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1). Due to the limited
number of publicly available deep sequencing libraries of high quality that represent
the same sampling location within the oral cavity (i.e., supra- or subgingival plaque and
saliva), we included libraries with mixed sample origin to represent healthy and disease
states, respectively (Table S2 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp
?task1ed182b005a74b94ac730f769b2f37b1). This could have created discrepancies in
our analysis, and differences that we present here may represent differences between
sampling location and not between oral health states. In addition, DNAs from 47 saliva
samples representing 23 children with caries and 24 healthy children were sequenced,
and putative BGCs were identified. Nonsupervised exploratory ordination through
FIG 2 Legend (Continued)
Subnetworks representing major BGC classes, as determined by antiSMASH and BiG-SCAPE, are highlighted with different
background colors to visualize BGCs as constellations within the biosynthetic landscape. Nodes (small circles) represent amino acid
sequences of BGC domains and are colored by BGC class. Unfilled nodes represent reference BGCs from the MIBiG repository. Edges
drawn between the nodes correspond to pairwise distances, computed by BiG-SCAPE as the weighted combination of the Jaccard,
adjacency, and domain sequence similarity indices. For increased simplicity, only subclusters of unclassified and oligosaccharide
BGCs with a minimum number of eight nodes are organized into given highlighted constellation.
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PCoA revealed significant differences in the representation of BGCs between healthy
and diseased subjects in five of the six metatranscriptome studies and six of the seven
metagenome studies investigated (Fig. 3). The 1,804 BGCs which were differentially
represented in health versus disease in the metagenomes and metatranscriptomes are
summarized in Table 1.
The BGCs associated with disease in the metatranscriptome studies were related to
the synthesis of a broad range of small molecule types. These types particularly
included BGCs of the oligosaccharide, aryl polyene, terpene, bacteriocin, and NRPS
classes (Fig. 4). BGCs encoding PKS, NRPS, and bacteriocins from Actinomyces, Rothia,
and Corynebacterium had increased expression in subjects with caries, while BGCs
encoding terpenes and aryl polyenes from Neisseria spp. and Proteobacteria had
increased expression in healthy subjects (Fig. 4). Previous studies illustrated that aryl
polyenes act as protective agents against oxidative stress and that terpenes function as
anti-inflammatory agents (40). These findings are in line with previous findings that
high levels of Actinomyces were associated with severe childhood caries (44). In the
caries-associated samples, known cariogenic species belonging to the Streptococcus,
Veillonella, and Lactobacillus genera (45) showed notable changes in bacteriocin and
oligosaccharide BGC expression profiles (Fig. 4).
In periodontitis, a high number of differentially expressed BGCs (170 BGCs) were
identified in community members belonging to the Bacteroidetes phylum. Several BGCs
encoded by periodontal pathogens of the red and orange complexes (e.g., Porphy-
romonas gingivalis) were differentially expressed in health compared to periodontal
disease. Known red complex species had increased expression of BGCs belonging to
the aryl polyene, oligosaccharide, homoserine lactone, and resorcinol classes in dis-
eased states. Neisseria spp. also showed interesting signatures, such as increased
expression of BGCs belonging to the terpene, resorcinol, bacteriocin, and homoserine
lactone classes (Fig. 4). These results suggest that Neisseria spp. and its small molecules
may play a role in periodontitis, which is worth further explorations in future studies.
Homologs to specific BGC products in the MIBiG database which displayed differential
expression in health and disease are detailed in Fig. S2. Analysis of the metagenomic
studies yielded trends similar to those detailed above (Fig. 5).
Next, a subset of differentially represented BGCs, which showed high levels of
expression in either healthy or diseased states, was examined to determine whether
they commonly occur across studies. The results were visualized as a binary occurrence
matrix (Fig. S3). In all studies analyzed, only a minor fraction of the differential features
(10 BGCs) were shared between any two studies. The reason for this discrepancy may
be due to both biological and technical variations such as differences in anatomical
features at the collection site of dental plaque and what time of the day saliva samples
were collected. Additionally, sequencing platforms, methodological variations in sam-
ple collection, nucleic acid extraction techniques (with or without DNA or RNA/rRNA
removal methods), and use of different library preparation methods (see Table S2
posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a7
4b94ac730f769b2f37b1 and Fig. S4) may also play important roles. Given the complex-
ity of metagenomes and metatranscriptomes, these factors can certainly influence the
sequence composition and lead to the differences we observed here. It is also impor-
tant to note that due to the fact that BGCs can be horizontally transferred between
different bacterial species, mRNA read mapping to BGC databases does not provide
definite taxonomic classification and predictions of species-level activities.
Differential interactions between BGCs and oral taxa in caries and health. To
examine possible relationships between BGCs and bacterial taxa during health and
disease, a focused comparative analysis of the shotgun metagenomics data obtained in
this study from saliva samples from healthy children and children with caries (Table S1
posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b
94ac730f769b2f37b1) was performed. Children in the caries group had a minimum of
two active caries lesions. No overall differences in diet or oral hygiene habits (brushing
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FIG 3 Principal coordinate analysis (PCoA) of BGC profiles representing oral bacterial communities in health and disease. (A) Metatranscriptomics (MT) of BGC
profiles from healthy individuals versus individuals with periodontitis from Duran-Pinedo et al. (17). (B) Metatranscriptomics of healthy versus periodontitis
BGC profiles from Belstrom et al. (18). (C) Metatranscriptomics of stable versus progressive periodontitis profiles from Jorth et al. (19). (D) Metatranscriptomics
of healthy versus caries profiles from Yost et al. (20). (E) Metatranscriptomics of healthy versus caries profiles from Do et al. (21). (F) Metatranscriptomics of
healthy versus caries profiles from Peterson et al. (22). (G) Metagenomics (MG) of BGC profiles from healthy individuals versus individuals with periodontitis from
Wang et al. (23). (H) Metagenomics of resolved versus periodontitis profiles from Shi et al. (24). (I) Metagenomics of healthy versus caries profiles from
Belda-Ferre et al. (25). (J) Metagenomics of healthy versus periodontitis profiles from Belstrom et al. (18). (K) Metagenomics of healthy versus caries profiles
from Belstrom et al. (18). (L) Metagenomics of stable versus progressive periodontitis profiles from Yost et al. (20). (M) Metagenomics of healthy versus caries
in the current study. PCoA analyses are based on differentially represented BGCs calculated by using the DESeq2 package with false discovery rate (FDR)
correction of 0.05. Manhattan distances between samples were visualized using the first three principal coordinates, and significance was tested by applying
Mann-Whitney ranks on the most variance captured by the first principal coordinate.
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and flossing) were recorded between the groups. Also, gingiva index scores, which
measure oral health were low for both groups (below 1.0) and not significantly different
(P  0.05, Table S1 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task
1ed182b005a74b94ac730f769b2f37b1), suggesting that both groups presented with
good overall gingival health, except for cavities in the caries active group. Interactions
between BGCs and microbial taxa were examined by employing cooccurrence network
analysis using the SparCC algorithm, which has the benefit of limiting the number of
spurious correlations identified due to species data being compositional (46). While
positive correlations were more evident among taxon-taxon relationships (i.e., different
taxa benefit from one another’s presence), almost all significant correlations that were
identified between specific BGCs and taxa were negative (Table S1 posted at https://
massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1 and
Fig. S5 and S6). This suggests that antagonistic relationships, modulated through
BGC-produced antimicrobial molecules, are highly significant to the ecology of the oral
microbiome.
All BGCs that had significant correlations to oral taxa (a total of 36) were annotated
as close homologs to previously characterized BGCs belonging to the PKS, NRPS,
NRPS-PKS hybrid, oligosaccharide, and aryl polyene classes (Fig. S1). In the oral micro-
biomes derived from healthy children, the interaction network was dominated by
negative correlations between oral taxa and BGCs producing glycopeptidolipids, cap-
sular polysaccharides, as well as a homolog of flexirubin (Fig. S5A and Table S1 posted
at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f
769b2f37b1). The glycopeptidolipids were encoded by the opportunistic pathogens
Kytococcus sedentarius and Mycobacterium neoaurum and were primarily shown to vary
inversely with the oral taxa Lactobacillus, Prevotella, Capnocytophaga, and Enterococcus
(Fig. S5A and Table S1 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task
1ed182b005a74b94ac730f769b2f37b1). The flexirubin homolog BGCs were encoded
TABLE 1 Differentially represented or expressed biosynthetic pathways in samples from




Caries Periodontitis Caries Periodontitis
Aryl polyene 4/11 29/4 26/5 25/3
Bacteriocin 14/10 1/1 31/1 5/24
Butyrolactone 2/0 1/1 3/0 1/1
Homoserine lactone 0/4 3/4 10/0 1/1
Lantipeptide 7/0 4/0 11/2 1/6
Lassopeptide 0 0 0 0/3
NRPS 7/0 2/8 11/7 10/14
NRPS-PKS hybrid 1/0 0/1 5/0 0/1
Oligosaccharide 66/68 100/40 116/118 287/132
Other 7/0 2/11 36/3 16/15
Phenazine 0 0/1 2/0 0/1
PKS 3/0 1/0 8/0 1/4
Proteusin 0 0 1/0 1/0
Resorcinol 1/4 3/8 4/4 19/0
Sactipeptide 0 0 0 1/0
Siderophore 1/0 1/2 0 1/0
Terpene 1/10 9/1 42/0 1/4
Thiopeptide 1/0 0 0 0/7
Unclassified 93/50 62/121 209/86 300/177
aNumber of differentially represented or expressed biosynthetic pathways in saliva, supra- and subgingival plaque
samples, from shotgun metatranscriptomic and metagenomic libraries representing 231 subjects (oral healthy
individuals [n  110] and individuals with dental caries [n  77] or periodontitis [n  44]). A total of 741 BGCs
were differentially abundant in individuals with caries (515 enriched and 226 less abundant), and 1,063 BGCs
were associated with periodontitis (670 enriched and 393 less abundant). A total of 355 BGCs were differentially
expressed in caries (208 upexpressed and 147 downexpressed), while 421 BGCs were either up- or
downexpressed in subjects with periodontitis (218 upexpressed and 203 downexpressed).
bValues in the table are the numbers of BGCs upexpressed/numbers of BGCs downexpressed in individuals
with caries or periodontitis.
Aleti et al. ®
March/April 2019 Volume 10 Issue 2 e00321-19 mbio.asm.org 10
 on N
ovem









Prevotella sp oral taxon 299 str F0039
Streptococcus australis ATCC 700641
Neisseria meningitidis ATCC 13091
Prevotella veroralis DSM 19559
Veillonella sp ACP1
Leptotrichia sp oral taxon 879 str F0557
Prevotella saccharolytica F0055
Oribacterium sp oral taxon 78 str F0262
Prevotella pallens ATCC 700821
Prevotella fusca J CM 17724
Pseudomonas otitis strain LNU E 001
Prevotella oris DSM 18711 J CM 12252
Parvimonas sp oral taxon 110 str F0139
Pseudoramibacter alactolyticus ATCC 23263
Pseudomonas fluorescens Pf0 1
Campylobacter showae RM3277
Megasphaera micronuciformis F0359
Haemophilus sp oral taxon 851 str F0397
Haemophilus aegyptius ATCC 11116
Leptotrichia sp oral taxon 215 str W9775
Veillonella sp 6 1 27
Porphyromonas gingivalis W83
Delftia acidovorans SPH 20
Selenomonas sp oral taxon 149 str 67H29BP
Streptococcus mitis B6
Prevotella denticola DSM 20614 J CM 13449
Klebsiella pneumoniae 342
Actinomyces sp oral taxon 848 str F0332
Neisseria lactamica 020 06
Neisseria mucosa ATCC 25996
Streptococcus oralis Uo5
Delftia acidovorans SPH 30
Capnocytophaga sp oral taxon 338 str F0234
Actinomyces sp oral taxon 178 str F0338
Eikenella corrodens ATCC 23834
Streptococcus sp F0442
Capnocytophaga sp oral taxon 336 str F0502
Filifactor alocis ATCC 35896
Neisseria bacilliformis ATCC BAA 1200
Prevotella loescheii J CM 12249 ATCC 15930 strain DSM 19665
Fusobacterium nucleatum subsp animalis F0419 strain OT 420
Variovorax paradoxus S110
Leptotrichia hofstadii F0254
Selenomonas artemidis DSM 19719
Haemophilus haemolyticus M21639 M21639 021
Leptotrichia buccalis DSM 1135
Prevotella melaninogenica ATCC 25845
Capnocytophaga sp oral taxon 326 str F0382
Propionibacterium acidifaciens DSM 21887
Veillonella parvula DSM 2008
Candidate division TM7
Fretibacterium fastidiosum
Tannerella sp oral taxon286
Prevotella sp oral taxon 473 str F0040
J ohnsonella ignava ATCC 51276
Bradyrhizobium elkanii 587
Actinomyces gerencseriae DSM 6844
Neisseria subflava NJ 9703
Rothia aeria F0474
Campylobacter gracilis strain ATCC 33236
Brevundimonas diminuta 470 4
Actinomyces timonensis DSM 23838 strain 7400942
Haemophilus parainfluenzae t3t1
Capnocytophaga sp oral taxon 335 str F0486
Fusobacterium periodonticum ATCC 33693
Actinomyces sp oral taxon 448 str F0400
Streptococcus pneumoniae AP200
Veillonella sp oral taxon 158 str F0412
Synergistetes sp SGP1
Lactobacillus casei BL23
Streptococcus mitis ATCC 6249
Streptococcus peroris ATCC 700780
Neisseria meningitidis MC58
Delftia acidovorans SPH 19
Parascardovia denticolens F0305
Veillonella sp hpa0037
Delftia acidovorans SPH 9
Neisseria sicca ATCC 29256
Achromobacter xylosoxidans A8
Alloprevotella tannerae ATCC 51259
Oribacterium sinus F0268
Oribacterium sp oral taxon 108 str F0425
Pseudomonas protegens Pf 5
Capnocytophaga gingivalis ATCC 33624
Prevotella tannerae ATCC 51259
Rothia dentocariosa ATCC 17931
Prevotella scopos
Lachnoanaerobaculum saburreum DSM 3986
Haemophilus influenzae PittGG
Actinomyces sp oral taxon 175 str F0384
Streptococcus constellatus subsp pharyngis CCUG
Selenomonas flueggei ATCC 43531
Actinomyces oris K20
Leptotrichia sp oral taxon 225 str F0581
Prevotella veroralis F0319
Prevotella nigrescens ATCC 33563
Treponema socranskii subsp paredis ATCC 35535
Prevotella sp oral taxon 472 str F0295
Neisseria sp oral taxon 14 str F0314
Neisseria lactamica ATCC 23970
Pseudomonas stutzeri A1501
Prevotella intermedia
Fusobacterium nucleatum subsp vincentii ATCC 49256
Prevotella melaninogenica D18
Campylobacter rectus RM3267
Tannerella sp oral taxon BU063
Streptococcus gordonii str Challis
Rothia dentocariosa M567
Mogibacterium timidum ATCC 33093
Streptococcus mutans UA159
Olsenella profusa F0195
Lactobacillus rhamnosus GG ATCC 53103
Aggregatibacter aphrophilus NJ 8700
Burkholderia cepacia GG4
Desulfobulbus sp oral taxon 41 str Dsb3
Porphyromonas sp oral taxon 279 str F0450
Eubacterium saburreum
Tannerella forsythia ATCC 43037
Veillonella parvula ATCC 17745
Delftia acidovorans SPH 1
Veillonella atypica ACS 134 V Col7a
Stenotrophomonas maltophilia R551 3
Lactobacillus fermentum IFO 3956
Atopobium rimae ATCC 49626
Corynebacterium durum F0235
Capnocytophaga ochracea DSM 7271
Actinomyces israelii DSM 43320
Haemophilus haemolyticus M21639 M21639 006
Ralstonia pickettii 12D
Veillonella parvula strain SHI 1
Aggregatibacter segnis ATCC 33393
Streptococcus oligofermentans AS 1 3089
Porphyromonas sp oral taxon 278 str W7784
Corynebacterium urealyticum DSM 7109
Leptotrichia wadei DSM 19758
Capnocytophaga granulosa ATCC 51502
Streptococcus anginosus subsp whileyi CCUG
Mesorhizobium loti MAFF303099
Prevotella scopos J CM 17725
Selenomonas sp oral taxon 892 str F0426
Leptotrichia goodfellowii F0264
Prevotella denticola F0289
Capnocytophaga sp oral taxon 863 str F0517
Gemella haemolysans M341
Lautropia mirabilis ATCC 51599
Prevotella salivae DSM 15606
Selenomonas artemidis F0399
Prevotella sp oral taxon 306 str F0472
Actinomyces viscosus C505
Treponema medium ATCC 700293
Actinomyces sp oral taxon 180 str F0310
Veillonella sp 3 1 44
Kingella oralis ATCC 51147
Fusobacterium nucleatum subsp polymorphum ATCC 10953
Parascardovia denticolens J CM 12538 strain DSM 10105
Neisseria gonorrhoeae DGI2
Selenomonas sputigena ATCC 35185
Escherichia coli BW2952
Streptococcus parasanguinis ATCC 15912
Actinomyces sp oral taxon 171 str F0337
Streptococcus mitis NCTC 12261
Prevotella sp oral taxon 317 str F0108
Corynebacterium matruchotii ATCC 33806
Actinomyces massiliensis 4401292
Sanguibacter keddieii DSM 10542
Kingella denitrificans ATCC 33394
Fusobacterium sp 4 8
Prevotella shahii DSM 15611 J CM 12083
Simonsiella muelleri ATCC 29453
Prevotella baroniae DSM 16972 J CM 13447
Eubacterium yurii subsp margaretiae ATCC 43715
Enterobacter cancerogenus ATCC 35316
Veillonella dispar ATCC 17748
Centipeda periodontii DSM 2778
Neisseria flavescens NRL30031 H210




Leptotrichia shahii DSM 19757
Actinomyces sp oral taxon 849 str F0341
Prevotella shahii DSM 15611
Parvimonas micra ATCC 33270
Campylobacter showae CSUNSWCD
Porphyromonas gingivalis ATCC 33277
Prevotella intermedia ATCC DSM 20706
Pseudomonas pseudoalcaligenes KF707
Delftia acidovorans SPH 23
Lachnospiraceae oral taxon 107 str F0167
Fusobacterium sp oral taxon 370str F0437
Capnocytophaga sputigena ATCC 33612
Aggregatibacter sp oral taxon 458 str W10330
Bacteroidetes oral sp
Escherichia coli O157 H7 str EC4115
Prevotella veroralis
Rothia mucilaginosa DY 18
Leptotrichia hofstadii DSM 21651
Haemophilus parainfluenzae ATCC 33392
Bordetella pertussis strain Tohama I
Neisseria elongata subsp glycolytica ATCC 29315
Brevundimonas diminuta ATCC 11568
Streptococcus anginosus DSM 20563 strain
Streptococcus salivarius SK126
Selenomonas noxia ATCC 43541
Prevotella multiformis DSM 16608
Campylobacter gracilis RM3268
Neisseria gonorrhoeae NCCP11945
Bradyrhizobium elkanii USDA 76
Scardovia wiggsiae F0424
Capnocytophaga sp oral taxon 412 str F0487
Actinomyces dentalis DSM 19115
Treponema denticola ATCC 35405










FIG 4 BGCs are differentially expressed in oral health and disease. Bar graphs illustrating phylogenetic distribution of biosynthetic pathways in oral health-
and disease-associated oral microorganisms. Taxa with significant changes in BGC expression based on the analyzed metatranscriptomic data sets are shown
in the phylogenetic tree on the left. Bacterial genomes associated with periodontal disease and that belong to the red and orange complexes are labeled in
(Continued on next page)
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by Actinomyces massiliensis and Prevotella oralis and displayed antagonistic activity
against 122 taxa, including Streptococcus mutans, historically considered the primary
etiologic species of dental caries (positive correlation coefficients included here range
between 0.8 and 1.0, and negative coefficients range between 0.8 and 1) (Fig. S5A
and Table S1 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed18
2b005a74b94ac730f769b2f37b1). Additional negative correlation with S. mutans
ranged between 0.5 and 0.7 (data not shown here). Homologs of the antibiotics
bacillaene and pristinamycin (47, 48), harbored by genomes representing Propionibac-
terium propionicum F0230a and Actinomyces timonensis DSM 23838 displayed negative
correlations with several pathogenic taxa: Lactobacillus, Listeria, Lysinabacillus, Acineto-
bacter, Enterococcus, Neisseria, Staphylococcus, Kingella, and S. mutans (49) (Fig. S5A).
These associations are reminiscent of a previous study which observed similar
macrolide-encoding BGCs widely distributed among oral bacterial genomes (2). These
FIG 4 Legend (Continued)
orange and red. Bar graphs at the leaf tips display number of BGCs either up- or downexpressed and colored according to the BGC type. It should be noted
that the x-axis scales are different in the left and right panels. Significant differences in the expression of BGCs were determined based on negative binomial




FIG 5 Overview of differentially represented biosynthetic pathways in oral bacterial genomes in oral health and disease states based on metagenomic
data sets. Bacterial genomes associated with periodontal disease and that belong to the red and orange complexes are labeled in orange and red. (A)
740 differentially abundant BGCs in the salivary and supragingival microbiome in healthy individuals and individuals with caries, representing 69
subjects (healthy individuals [n  34]; individuals with caries [n  35]). (B) 1,065 differentially abundant BGCs in metagenomes obtained from saliva and
subgingival plaque samples from individuals with periodontitis and healthy controls, representing 49 subjects (oral health [n  25]; periodontitis
[n  24]). Taxonomic units with significant changes in BGC representation are shown in the phylogenetic tree. Bar graphs at the leaf tips are colored
according to the BGC type and display numbers of BGCs expressed higher or lower. Noted that the x-axis scales are different for the left and right panels.
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macrolide structures were also reported to inhibit the growth of cariogenic streptococci
(50). This collective evidence indicates that the isolation and characterization of
bacillaene- and pristinamycin-like molecules in future studies may be key to under-
standing important health-protective mechanisms in the oral cavity. Finally, P. propi-
onicum F0230a encoded a BGC with high sequence homology to a nonribosomal
peptide pathway encoding the genotoxin colibactin (51). This BGC showed antagonistic
associations with pathogenic genera: Haemophilus, Aggregatibacter, Parascardovia,
Capnocytophaga, and Streptococcus (Table S1 posted at https://massive.ucsd.edu/
ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1).
Most intriguingly, the number of significant correlations between BGCs and micro-
bial taxa was dramatically reduced in the samples derived from children with caries
(Fig. S6A to C). This may indicate that in the oral cavities exhibiting disease, the
well-documented colonization resistance of the oral microbiome may be impaired. Of
the few significant correlations between BGCs and taxa within the interaction network
of the caries-associated microbiome, the vast majority involved BGCs encoding RiPPs
with close homology to nosiheptide and hygromycin BGCs (Fig. S5B; Table S1 posted
at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f
769b2f37b1). The nosiheptide-like BGC, encoded in the genome of Corynebacterium
matruchotii, was the most predominant, with antagonistic interactions against 90
taxa. These taxa included pathogens from the Klebsiella, Helicobacter, Filifactor, Hae-
mophilus, Enterococcus, and Fusobacterium genera (Fig. S5B; Table S1 posted at https://
massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1).
The hygromycin-like BGC from P. propionicum negatively correlated with several patho-
gens belonging to the genera Lactobacillus, Neisseria, Klebsiella, Anaerococcus, and
Pseudoramibacter. Interestingly, there were no significant correlations between S. mu-
tans and BGCs in the caries-associated oral microbiomes, which suggests that during
disease, the community lacks the ability to limit the abundance of this cariogenic
pathogen. Taken together, these results show that in the oral microbiome, exclusion of
particular taxa via antagonistic interactions, mediated by the products of BGCs, is
widespread. Although such interactions were still present in the caries-associated oral
microbiomes, there were fewer interactions. This underscores the importance of ecol-
ogy and the role of BGC-produced small molecules in the balance between health and
disease.
Homologs of BGC-produced small molecules are present in oral metabolomes
associated with caries and health. To validate the production of small molecules from
the differentially abundant BGCs that we identified in the analysis above (Fig. 3M), we
performed untargeted liquid chromatography-tandem mass spectrometry (LC-MS/MS)
analysis of the same saliva samples. Utilizing the Global Natural Products Social
Molecular Networking (GNPS) (52) analysis platform, a mass spectral molecular network
consisting of 1,369 mass spectral features grouped into 69 molecular families (two or
more connected components of a graph) was obtained. Fifty matches were acquired
between the query MS/MS spectra and characterized reference spectra from GNPS. To
further enhance mass spectrometry annotations and to link annotations to known
chemical structures encoded by BGCs, major chemical classes were putatively identified
by integrating mass spectral molecular networking with in silico annotations and
automated chemical classification approaches (53–55). This allowed identification of
approximately 38% of the nodes in the mass spectral molecular network at the
chemical class level. The most predominant chemical classes within the network were
carboxylic acids and derivatives, prenol lipids, fatty acyls, and flavonoids (Fig. S7).
Substructures associated with macrolides, terpenoids, and macrolactams were also
identified. At the chemical class level, there were no distinct relative abundance
patterns between the oral health- and disease-associated samples. This is in stark
contrast to PCoA analysis of the 1,369 MS features, which showed clear separation of
samples between healthy and diseased states (Fig. 6A) rather than by DMFT scores
(Fig. 6B), dentition stage (Fig. 6C), race (Fig. 6D), and age (Fig. 6E), in agreement with
the BGC abundance profiles (Fig. 3M). By employing a random forest importance
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FIG 6 Analysis of small molecules shows clear differences between saliva samples derived from healthy children compared to children with caries. (A)
Principal coordinate analysis (PCoA) of parent masses (m/z) derived from LC-MS/MS analysis of saliva. Manhattan distances between samples were
visualized, and significance was tested by applying Mann-Whitney ranks on the principal coordinates (P  0.0001). (B) PCoA based on DMFT (decayed,
missed, or filled teeth) scores (P  0.05). (C) PCoA based on primary and mixed dentition (primary and permanent teeth) (P  0.05). (D) PCoA based on
race (P  0.05). (E) PCoA based on age (P  0.05). (F) Fifteen key metabolites responsible for the PCoA separation identified by a random forest
importance model.
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model, 15 key metabolites, which were distinct between healthy and disease states
(Fig. 6F), were identified. Of these, 12 were significantly more abundant in healthy
subjects, while 3 were more abundant in the subjects with dental caries. Out of the
three key metabolites that were significantly more abundant in the diseased subjects,
two matches were obtained to lipid compounds from GNPS reference spectra resulting
in a level 2 metabolite identification (56). These matches were N-nervonoyl-D-erythro-
sphingophosphorylcholine and 13-docosenamide. These molecules are likely to origi-
nate from the human host and warrant further investigation.
Using the in silico Network Annotation Propagation tool (NAP) (57), putative struc-
tural matches were obtained for 6 out of the 12 key metabolites that were more
abundant in the healthy subjects, including terpenoids, phenylpropanoids, as well as
fatty alcohols. It should be noted however, that one of the limitations of in silico
annotation is the uncertainty around the correct structure among the predicted
candidate structures. Results should therefore be interpreted with care, and an accurate
prediction of the putative identity would require follow-up investigations, which is
outside the scope of the present study. It should be also noted that both the genomic
and metabolomic approaches employed identify putative homologs and not exact
matches. Thus, using current techniques and databases, it is not possible to definitively
determine whether the small molecules identified by LC-MS/MS were in fact produced
by the specific BGCs predicted by antiSMASH. However, the LC-MS/MS analyses largely
support the results of the genomic analyses by detecting classes of small molecules and
homologs which were similar to those discovered by the complementary BGC genom-
ics analyses.
Concluding remarks. This study significantly expands the number of identified
BGCs encoded by bacteria of the human oral microbiome and designates putative
products to many novel clusters. Representation and expression of the newly identified
BGCs, as well as their relationship to the abundance of oral bacterial taxa were
examined during health, dental caries, and periodontitis, revealing significant differ-
ences in microbial social ecology and communication among the three host outcomes.
This work provides an atlas for further examination and experimental validation of the
identified socio-chemical relationships and their role in the pathogenesis of dental
caries and periodontal disease. A deeper elucidation of the social activities of the
microbes residing in the oral cavity will significantly improve our understanding of the
pathogenesis of oral (and extraoral) diseases and will guide development of improved
therapeutic strategies to maintain oral health.
MATERIALS AND METHODS
The ethics statement is provided in Text S1 (Supplementary Materials and Methods section) in the
supplemental material.
Study inclusion/exclusion criteria and collection of saliva. Subjects were included in the study if
the subject was 3 years old or older and in good general health according to a medical history and
clinical judgment of the clinical investigator, subjects had at least 12 teeth. Subjects in the caries group
had a supragingival (above the gum line) plaque score of 1 or greater on a scale of 0 to 3. Subjects were
excluded from the study if they had generalized rampant dental caries, chronic systemic disease, or
medical conditions that would influence the ability to participate in the proposed study (i.e., cancer
treatment, HIV, rheumatic conditions, history of oral candidiasis). Subjects were also excluded it they had
open sores or ulceration in the mouth, radiation therapy to the head and neck region of the body,
significantly reduced saliva production or had been treated by anti-inflammatory or antimicrobial
therapy. Ethnic origin was mixed for healthy subjects (Hispanic, Asian, Caucasian, Caucasian/Asian), while
children with caries were of Hispanic origin. For the latter group, no other ethnic group enrolled despite
several attempts to identify interested families/participants. Children with both primary and mixed
dentition stages were included (caries group: 18 children with mixed dentition and 6 with primary
dentition; healthy group: 19 children with mixed dentition and 6 with primary dentition). To further
enable classification of health status (here caries and healthy), a comprehensive oral examination of each
subject was performed by a single calibrated pediatric dental resident, using a standard dental mirror,
illuminated by artificial light. The visual inspection was aided by tactile inspection with a community
periodontal index (CPI) probe when necessary. The number of teeth present was recorded, and dental
caries status was recorded using decayed (d), missing due to decay (m), or filled (f) teeth (t) in primary
and permanent dentitions (dmft/DMFT), according to the criteria proposed by the World Health
Organization in 1997. Duplicate examinations were performed on five randomly selected subjects to
assess intraexaminer reliability. Subjects were dichotomized into two groups: caries free (dmft/DMFT  0)
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and caries active (subjects with 2 active dentin lesions). If the subject qualified for the study, (s)he was
asked to brush their teeth after breakfast and abstain from eating and drinking for 2 h prior to saliva
collection in the morning. According to a previously developed protocol (58), to ensure that the mouth
was free of food or foreign substances, each volunteer rinsed their mouth three times with water 10 min
prior to saliva collection. Following the same protocol, we collected approximately 2 ml saliva from each
subject by having the subject spit directly in a sterile 15-ml Falcon tube over a 20-min period. Whole
saliva was immediately transferred to sterile 2-ml cryovial tubes and snap-frozen for long term storage
at 80˚C. For more information, see Text S1 (Supplementary Materials and Methods section) in the
supplemental material.
DNA extraction and metagenomic sequencing. For detailed protocols of DNA extraction and
metagenomic sequencing, see Text S1 (Supplementary Materials and Methods section).
BGC identification and network analysis of known and putative oral BGCs. A list of 1,362
described and curated human oral taxa (18 September 2017) was obtained from the Human Oral
Microbiome Database (HOMD) (55). A few genomes belonging to transient exogenous bacterial taxa,
which also have oral taxon IDs in HOMD were also added to this list (e.g., legume symbiont Mesorhizo-
bium loti, pathogenic Yersinia pestis). In order to identify small-molecule- and secondary metabolite-
encoding BGCs in the genomes of bacterial taxa representative of a broad oral bacterial diversity, 461
complete and high-quality draft genomic sequences, annotated as dynamic and static, were obtained
from the National Center of Biotechnology Information genome database (https://www.ncbi.nlm.nih
.gov/genome), as well as from an in-house database (Table S1 posted at https://massive.ucsd.edu/
ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1). These sequences were concate-
nated into a major query-database and fed to antiSMASH (Antibiotics & Secondary Metabolite Analysis
Shell, version 4.0) (29). Multiple nucleotide FASTA sequences from BGCs were constructed. We excluded
a list of 320 previously described nonbiosynthetic genes commonly found in BGCs (2) (Table S1 posted
at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b94ac730f769b2f37b1) based
on text within an attribute using advanced filter settings in CLC Workbench software v. 9. (CLCbio, Aahus,
Denmark). The resulting data set contained a total of 192,283 gene sequences from 4,915 BGCs and can
be downloaded from the MassIVE repository (ftp://massive.ucsd.edu/MSV000081832) with the accession
ID MSV000081832. For more information, see Text S1 (Supplementary Materials and Methods section).
Comparison of BGCs with known biosynthetic pathways. A reference MIBiG database comprising
multiple amino acid sequences for each BGC was constructed using MultiGeneBlast (30). To further
compare BGCs (excluding the fatty acid synthase encoding BGCs) derived from oral bacterial genomes
with those encoding the biosynthetic pathways for known compounds, we performed multigene
homology searches using complete gene cluster sequences against the MIBiG database by using the
stand-alone version of MultiGeneBlast (http://multigeneblast.sourceforge.net/) algorithm with default
settings. Subsequently, for each queried BGC, we extracted information from the top hit (with the highest
cumulative BLAST bit score) from an output of multiple BLAST hits using an in-house python script. For
additional information, see Text S1 (Supplementary Materials and Methods section).
16S rRNA gene (16S) phylogenetic analysis. For a detailed protocol of 16S rRNA gene phylogenetic
analysis, see Text S1 (Supplementary Materials and Methods section).
Metagenomic and metatranscriptomic data collection. Shotgun metatranscriptomic and metag-
enomic sequencing data published previously by Duran-Pinedo et al. (22), Belda-Ferre et al. (23), Belstrøm
et al. (24), Jorth et al. (59), Do et al. (25), Peterson et al. (26), Yost et al. (27), Wang et al. (28), and Shi et
al. (60), as well as our own study of metagenomes from saliva samples obtained from children with good
dental health and children with dental caries was analyzed (sequence reads are accessible under
BioProject accession no. PRJNA1234; Table S2 posted at https://massive.ucsd.edu/ProteoSAFe/status.jsp
?task1ed182b005a74b94ac730f769b2f37b1). For a detailed protocol, see Text S1 (Supplementary
Materials and Methods section).
Differential abundance and expression analyses of BGCs. We employed a systematic workflow for
analyzing abundance and expression profiles of the BGCs. Using SRA toolkit utilities, reads were extracted
from metatranscriptome and metagenome shotgun sequenced libraries available via NCBI. For a detailed
protocol, see Text S1 (Supplementary Materials and Methods section).
Principal coordinate analysis. The differences between samples from healthy versus diseased
individuals was investigated by applying principal coordinates analysis (PCoA) on Manhattan distances
generated on the DESeq2-normalized count file using the EMPeror (61) tool. For a detailed protocol, see
Text S1 (Supplementary Materials and Methods section).
Correlation network analysis. The correlation network was constructed using the SparCC algorithm
(46) python package (available at https://bitbucket.org/yonatanf/sparcc) to represent both coabundance
and coexclusion networks between species and corresponding BGCs. For a detailed protocol, see Text S1
(Supplementary Materials and Methods section).
Experimental small molecule metabolite detection. Approximately 150 l of saliva was lyophi-
lized, and ethyl acetate was added to extract nonpolar molecules. Samples were then vortexed,
centrifuged to remove the cell debris, and submitted to untargeted LC-MS/MS analysis. For a detailed
protocol, see Text S1 (Supplementary Materials and Methods section).
Mass spectral molecular networking. LC-MS/MS spectra obtained from 49 saliva samples (25
healthy subjects and 24 subjects with caries) were preprocessed for feature extraction using MZmine2
(62) and submitted to mass spectral molecular networking through GNPS (43). For a detailed protocol,
see Text S1.
Aleti et al. ®
March/April 2019 Volume 10 Issue 2 e00321-19 mbio.asm.org 16
 on N
ovem








Putative chemical structure annotation. To putatively annotate chemical structures in our mass
spectral molecular networks, we performed in silico structure annotation through Network Annotation
Propagation (NAP) (57) both for [MH] and [MNa] adducts. For a detailed protocol, see Text S1.
Availability of data and material. Sequence data have been submitted to NCBI under BioProject ID
PRJNA478018 with SRA accession no. SRP151559. Mass spectral files, LC-MS/MS metadata file, and
Nucleotide FASTA sequences of the oral biosynthetic gene cluster collection are accessible from the
MassIVE repository (ftp://massive.ucsd.edu/MSV000081832) with the accession ID MSV000081832. Tables
S1 and S2 are available at https://massive.ucsd.edu/ProteoSAFe/status.jsp?task1ed182b005a74b
94ac730f769b2f37b1.
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